SAMe-TT2R2 Score in the OutpatientAnticoagulation Clinic to Predict Time in Therapeutic Range and AdverseEvents

摘要

BackgroundThe SAMe-TT2R2 score was developed to predict which patients on oral anticoagulation with vitamin K antagonists (VKAs) will reach an adequate time in therapeutic range (TTR) (> 65%-70%). Studies have reported a relationship between this score and the occurrence of adverse events.